Loading company…
Mailin Lanrui develops microneedle technology and transdermal delivery products.
Founded in 2023 and based in Xiamen, China, Mailin Lanrui develops microneedle platform technology based on marine-derived sponge spicules. Its products include microneedle materials, skincare formulations, dermatology devices and drug and vaccine delivery systems for medical aesthetics, dermatology and pharmaceutical research. The company generates revenue through technology licensing and sales of skincare and medical devices. It raised venture funding in March 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in